Streetbeat News

GEG

Great Elm Group, Inc.

https://www.greatelmgroup.com

Industry

Medical - Distribution

Great Elm Group, Inc. engages in the durable medical equipment and investment management businesses. The company distributes respiratory care equipment, including positive air pressure equipment and supplies, ventilators and oxygen equipment, and replacement parts, as well as provides sleep study services; and rents medical equipment. It also offers investment management services. The company was formerly known as Great Elm Capital Group, Inc. and changed its name to Great Elm Group, Inc. in December 2020. Great Elm Group, Inc. was founded in 1994 and is headquartered in Waltham, Massachusetts.

Open

N/A

Mkt cap

N/A

Volume

N/A

High

N/A

P/E Ratio

N/A

52-wk high

N/A

Low

N/A

Div yield

N/A

52-wk low

N/A

Great Elm Group (NASDAQ:GEG) reported a Q4 2024 GAAP EPS loss of $(0.02) per share, with sales increasing by 164.38% year-over-year to $8.000 million.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 8:22 pm

Great Elm Group (NASDAQ:GEG) reported a 46.84% increase in Q3 sales, reaching $2.787 million up from $1.898 million YoY.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 10:33 pm

Great Elm Group, Earth Science Tech, and Emmaus Life Sciences are under $2 stocks with recent insider buying activity. Great Elm Group saw a purchase by Imperial Capital Group Holdings II, LLC, while Earth Science Tech's CEO and Emmaus Life Sciences' Co-President and COO also made significant purchases. These transactions indicate insider confidence in these companies' prospects despite recent challenges such as losses and the announcement of a stock repurchase program.

Portfolio Pulse from Avi Kapoor

March 01, 2024 | 11:56 am

Great Elm Group (GEG) reported a Q2 EPS of $(0.01), a significant decrease from $0.48 YoY. However, sales increased to $2.82M from $1.88M YoY, marking a 50.03% growth.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 9:26 pm

Numerous companies are scheduled to report their quarterly earnings on February 13, 2024, with expectations spanning from significant profits to losses across various sectors. Key highlights include anticipated earnings from major corporations such as Coca-Cola, Shopify, Airbnb, and Biogen, reflecting a broad spectrum of industries from technology to consumer goods. The diversity in performance indicators underscores the varying financial health and market expectations for these entities.

Portfolio Pulse from Benzinga Insights

February 13, 2024 | 10:06 am

Insiders at four companies, Collective Audience, Great Elm Group, loanDepot, and CommScope Holding, have recently made significant stock purchases. These transactions can signal insider confidence in the companies' prospects. Collective Audience CEO Brent Suen bought 190,000 shares, Great Elm Group Director James Hugar acquired 5,042 shares, loanDepot CEO and President Frank Martell purchased 50,207 shares, and CommScope Holding CEO and President Charles Treadway bought 153,019 shares. These insider trades occur alongside various company updates, including a business combination for Collective Audience, a quarterly earnings miss for Great Elm Group, a wider-than-expected loss for loanDepot, and an analyst upgrade for CommScope.

Portfolio Pulse from Lisa Levin

November 17, 2023 | 2:19 pm

Great Elm Group (NASDAQ:GEG) reported Q1 earnings, missing estimated earnings by 81.4% with an EPS of $0.08 versus an estimate of $0.43. Revenue was down $15.27 million from the same period last year. Last quarter, the company also missed on EPS which was followed by a 2.75% drop in the share price.

Portfolio Pulse from Benzinga Insights

November 08, 2023 | 9:55 pm

Great Elm Group (NASDAQ:GEG) reported Q1 earnings of $0.08 per share, missing the analyst consensus estimate of $0.43 by 81.4%. This is a 127.59% increase over losses from the same period last year. The company's sales this quarter were $3.31 million, a 82.18% decrease from $18.58 million the same period last year.

Portfolio Pulse from totan@benzinga.com

November 08, 2023 | 9:52 pm

Several healthcare stocks experienced significant movement in Wednesday's after-market session. Inventiva, Bluejay Diagnostics, Xilio Therapeutics, Marinus Pharma, Dare Bioscience, and Alzamend Neuro saw increases, while Great Elm Group, 4D Molecular Therapeutics, Perspective Therapeutics, Avinger, Soligenix, and Oragenics experienced decreases. Great Elm Group's Q4 earnings were released on the same day.

Portfolio Pulse from Benzinga Insights

September 20, 2023 | 9:31 pm

Great Elm Group (NASDAQ:GEG) reported a significant decrease in sales for Q4, with $3.00 million in sales, down 83.39% from $18.07 million in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2023 | 8:13 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.